External Defibrillator Market Research Report: By Patient Type, End User

Description

List of Tables

One of the key reasons behind the growth of the global external defibrillator market is the rise in the prevalence of cardiovascular diseases (CVDs). As a result, the revenue generated from the sale of such devices is predicted to reach $9,450.3 million by 2030, from $3,926.5 million in 2019, at an 8.5% CAGR between 2020 and 2030.

According to the Heart Disease and Stroke Statistics-2017 Update report published by the American Heart Association (AHA), 800,000, or one in every three deaths in the U.S, is a direct result of CVDs. Defibrillators prove helpful in cardiac emergencies, by sending an electric shock to neutralize the abnormal current flowing through the sinoatrial and atrioventricular nodes, thus restoring the normal heart rhythm.

Due to the lockdown measures imposed in many countries, in the wake of COVID-19, manufacturing, export, and import activities have taken a bad hit, as has the supply of external defibrillators. However, the demand for such devices remains high, as medical settings are experiencing a rapid increase in the number of patients being hospitalized.

In the coming years, the non-wearable bifurcation, on the basis of type, is expected to witness more-rapid growth in the industry, as they are easy to use and portable. Moreover, wearable variants often cause sleep disturbance, skin rashes, sunburns, and itching, which is why patients and doctors prefer non-wearable external defibrillators.

The automatic bifurcation, based on technology, held larger share in the market during 2014-2019. This is because these variants require almost no technical expertise, which helps cardiac arrest or arrhythmia patients get immediate treatment, without the need to go to a proper medical facility. This is why they are being rapidly installed at airports, railway stations, shopping and sports complexes, and other public spaces.

Till 2030, the adult bifurcation, under the patient type segment, will continue dominating the industry, due to the higher prevalence of sudden cardiac arrest (SCA) in adult CVD patients, compared to pediatric subjects. The Heart Rhythm Clinic of Michigan (HRCM) says that 325,000 adults in the U.S. suffer from sudden cardiac death (SCD) every year.

North America is the largest user of external defibrillators, and it will continue being so till 2030. This is attributed to its advanced medical infrastructure, existence of numerous external defibrillator manufacturers, increasing geriatric population, rising CVD prevalence, and surging installation of AEDs in public places. In addition, several awareness programs and conferences are being initiated to educated people about the usefulness of AEDs in treating pulseless ventricular tachycardia and ventricular fibrillation (V-fib). For instance, Vancouver, Canada is scheduled to host the 28th International Congress on Cardiology and Medical Interventionson October 30-31, 2020.

In an effort to eliminate the competition and consolidate their own position in the industry, companies in the market are engaging in acquisitions.

For instance, in August 2019, the previously announced acquisition of Cardiac Science Corporation was completed by ZOLL Medical Corporation.

In the same vein, Physio-Control International Inc. was acquired by Stryker Corporation for $1.3 billion in February 2016. This way, Stryker Corporation expanded its portfolio of AEDs, monitors/defibrillators,CPR-assist devices, as well as data management and support services, along with its geographical reach.

The key companies in the global external defibrillator market are: Nihon Kohden Corporation, Koninklijke Philips N.V., Stryker Corporation, SCHILLER AG, Defibtech LLC, Progetti S.r.l., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Cardiac Science Corporation, Mediana Co. Ltd., ZOLL Medical Corporation, Opto Circuits India Ltd., BPL Medical Technologies Pvt. Ltd., and CU Medical System Inc.

Product Code: 12039

Chapter 1. Research Background

1.1. Research Objectives
1.2. Market Definition
1.3. Research Scope
- 1.3.1. Market Segmentation by Patient Type
- 1.3.2. Market Segmentation by End User
- 1.3.3. Market Segmentation by Region
- 1.3.4. Analysis Period
- 1.3.5. Market Data Reporting Unit
  - 1.3.5.1. Value
1.4. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
2.2. Primary Research
- 2.2.1. Split of Primary Research
- 2.2.2. Breakdown of Primary Research by Industry Participant
- 2.2.3. Breakdown of Primary Research by Company Type
- 2.2.4. Breakdown of Primary Research by Company Revenue and Corporate Designation
2.3. Baseline Methodology
2.4. Market Size Estimation
2.5. Data Triangulation
2.6. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1. Definition of Market Segments
- 4.1.1. By Patient Type
  - 4.1.1.1. Adult
  - 4.1.1.2. Pediatric
- 4.1.2. By End User
  - 4.1.2.1. Pre-hospital care and EMS providers
  - 4.1.2.2. Public access settings
  - 4.1.2.3. Homecare settings
  - 4.1.2.4. Hospitals, clinics, and cardiac centers
  - 4.1.2.5. Others
4.2. Market Dynamics
- 4.2.1. Trends
  - 4.2.1.1. Growing focus on installation of external defibrillators in public places
  - 4.2.1.2. Shifting focus from implantable devices to external defibrillators
  - 4.2.1.3. Increasing number of product launches
- 4.2.2. Drivers
  - 4.2.2.1. Advancements in external defibrillator technology
  - 4.2.2.2. Surging geriatric population
  - 4.2.2.3. Increasing number of strategic developments among key players
  - 4.2.2.4. Rising incidence of cardiac diseases
  - 4.2.2.5. Impact analysis of drivers on market forecast
- 4.2.3. Restraints
  - 4.2.3.1. Product failures
  - 4.2.3.2. Stringent regulatory norms
  - 4.2.3.3. Impact analysis of restraints on market forecast
- 4.2.4. Opportunities
  - 4.2.4.1. Awareness and training programs on defibrillation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Buyers
- 4.3.2. Bargaining Power of Suppliers
- 4.3.3. Intensity of Rivalry
- 4.3.4. Threat of New Entrants
- 4.3.5. Threat of Substitutes
4.4. Regulatory Scenario for External Defibrillators
- 4.4.1. North America
- 4.4.2. Europe
- 4.4.3. APAC
- 4.4.4. LATAM
- 4.4.5. MEA
4.5. Reimbursement Policies
4.6. Impact of COVID-19

Chapter 5. Global Market Size and Forecast

5.1. By Patient Type
5.2. By End User
5.3. By Region

Chapter 6. North America Market Size and Forecast

6.1. By Patient Type
6.2. By End User
6.3. By Country
- 6.3.1. U.S. External Defibrillator Market
  - 6.3.1.1. By patient type
  - 6.3.1.2. By end user

Chapter 7. Europe Market Size and Forecast

7.1. By Patient Type
7.2. By End User
7.3. By Country
- 7.3.1. Germany External Defibrillator Market
  - 7.3.1.1. By patient type
  - 7.3.1.2. By end user
- 7.3.2. France External Defibrillator Market
  - 7.3.2.1. By patient type
  - 7.3.2.2. By end user
- 7.3.3. U.K. External Defibrillator Market
  - 7.3.3.1. By patient type
  - 7.3.3.2. By end user
- 7.3.4. Italy External Defibrillator Market
  - 7.3.4.1. By patient type
  - 7.3.4.2. By end user
- 7.3.5. Spain External Defibrillator Market
  - 7.3.5.1. By patient type
  - 7.3.5.2. By end user

Chapter 8. APAC Market Size and Forecast

8.1. By Patient Type
8.2. By End User
8.3. By Country
- 8.3.1. Japan External Defibrillator Market
  - 8.3.1.1. By patient type
  - 8.3.1.2. By end user
- 8.3.2. India External Defibrillator Market
  - 8.3.2.1. By patient type
  - 8.3.2.2. By end user

Chapter 9. LATAM Market Size and Forecast

9.1. By Patient Type
9.2. By End User
9.3. By Country
- 9.3.1. Brazil External Defibrillator Market
  - 9.3.1.1. By patient type
  - 9.3.1.2. By end user
- 9.3.2. Mexico External Defibrillator Market
  - 9.3.2.1. By patient type
  - 9.3.2.2. By end user

Chapter 10. MEA Market Size and Forecast

10.1. By Patient Type
10.2. By End User
10.3. By Country
- 10.3.1. Saudi Arabia External Defibrillator Market
  - 10.3.1.1. By patient type
  - 10.3.1.2. By end user
- 10.3.2. South Africa External Defibrillator Market
  - 10.3.2.1. By patient type
  - 10.3.2.2. By end user

Chapter 11. Competitive Landscape

11.1. Competitive Analysis of the Key Players
11.2. Global Strategic Developments of Key Players
- 11.2.1. Product Launches
- 11.2.2. Acquisitions
11.3. List of Other Players

Chapter 12. Company Profiles

12.1. Koninklijke Philips N.V.
- 12.1.1. Business Overview
- 12.1.2. Product and Service Offerings
- 12.1.3. Key Financial Summary
12.2. Nihon Kohden Corporation
- 12.2.1. Business Overview
- 12.2.2. Product and Service Offerings
- 12.2.3. Key Financial Summary
12.3. SCHILLER AG
- 12.3.1. Business Overview
- 12.3.2. Product and Service Offerings
12.4. Stryker Corporation
- 12.4.1. Business Overview
- 12.4.2. Product and Service Offerings
- 12.4.3. Key Financial Summary
12.5. Progetti S.r.l.
- 12.5.1. Business Overview
- 12.5.2. Product and Service Offerings
12.6. Defibtech LLC
- 12.6.1. Business Overview
- 12.6.2. Product and Service Offerings
12.7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- 12.7.1. Business Overview
- 12.7.2. Product and Service Offerings
12.8. ZOLL Medical Corporation
- 12.8.1. Business Overview
- 12.8.2. Product and Service Offerings
12.9. Mediana Co. Ltd.
- 12.9.1. Business Overview
- 12.9.2. Product and Service Offerings
12.10. BPL Medical Technologies Private Limited
- 12.10.1. Business Overview
- 12.10.2. Product and Service Offerings
12.11. CU Medical System Inc.
- 12.11.1. Business Overview
- 12.11.2. Product and Service Offerings

Chapter 13. Appendix

13.1. Abbreviations
13.2. Sources and References
13.3. Related Reports